Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-020490
Filing Date
2015-04-01
Accepted
2015-04-01 14:29:37
Documents
1
Period of Report
2015-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v406311_3.html 3  
1 OWNERSHIP DOCUMENT v406311_3.xml 3 3224
  Complete submission text file 0001144204-15-020490.txt   4689
Mailing Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128 18889709463
Cell Source, Inc. (Issuer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELL SOURCE, INC. 65 YIGAL ALON STREET TEL AVIV L3 67433
Business Address
ZOLTY DAVID (Reporting) CIK: 0001638322 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55413 | Film No.: 15742646